Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE: 000766)

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	177.45	177.45	336.82	301.59	508.03	282.54
Short-Term Investments	-	-	-	-	-	6.8
Trading Asset Securities	1.05	1.05	0.13	0.18	-	-
Cash & Short-Term Investments	178.49	178.49	336.95	301.77	508.03	289.34
Cash Growth	-47.03%	-47.03%	11.66%	-40.60%	75.58%	-14.01%
Accounts Receivable	520.31	520.31	470.42	397.13	458.94	788.79
Other Receivables	34.81	34.81	35.76	61.52	113.54	166.02
Receivables	555.12	555.12	506.18	458.65	572.49	954.8
Inventory	369.17	369.17	381.37	384.58	435.27	409.28
Other Current Assets	8.43	8.43	13.87	6.68	13.28	34
Total Current Assets	1,111	1,111	1,238	1,152	1,529	1,687
Property, Plant & Equipment	1,026	1,026	1,053	1,087	1,004	1,027
Long-Term Investments	1,986	1,986	1,989	1,989	1,990	1,516
Goodwill	1.9	1.9	1.9	1.91	1.91	1.91
Other Intangible Assets	201.67	201.67	216.61	233.4	250.06	269.69
Long-Term Deferred Tax Assets	13.6	13.6	14.69	19.33	46.82	30.24
Long-Term Deferred Charges	173.46	173.46	160.89	153.31	141.31	135.71
Other Long-Term Assets	5.85	5.85	10.47	5.37	13.14	29.33
Total Assets	4,519	4,519	4,685	4,641	4,977	4,698
Accounts Payable	191	191	221.79	150.59	187.94	173.25
Accrued Expenses	17.05	17.05	48.23	38.79	30.35	64.11
Short-Term Debt	130.16	130.16	25.04	40.06	125.16	130
Current Portion of Long-Term Debt	12.86	12.86	204.59	1,625	162.84	249.98
Current Portion of Leases	-	-	0.29	0.26	-	-
Current Income Taxes Payable	20.37	20.37	5.52	0.79	9.36	5.19
Current Unearned Revenue	11.66	11.66	39.79	11.5	25.73	-
Other Current Liabilities	189.38	189.38	126.6	160.79	222.16	282.5
Total Current Liabilities	572.49	572.49	671.86	2,028	763.53	905.03
Long-Term Debt	1,557	1,557	1,564	183.75	1,814	983.21
Long-Term Leases	2.14	2.14	4.44	3.98	-	5.91
Long-Term Unearned Revenue	64.75	64.75	71.83	78.9	85.37	81.29
Long-Term Deferred Tax Liabilities	4.36	4.36	4.94	7.3	8.9	10.6
Other Long-Term Liabilities	-	-	-	-	-	46.02
Total Liabilities	2,201	2,201	2,317	2,301	2,672	2,032
Common Stock	966.49	966.49	966.49	966.49	966.49	966.49
Additional Paid-In Capital	3,579	3,579	3,642	3,642	3,642	3,642
Retained Earnings	-2,228	-2,228	-2,272	-2,302	-2,337	-1,978
Total Common Equity	2,318	2,318	2,337	2,307	2,271	2,631
Minority Interest	0.46	0.46	31.64	32.6	33.89	35.05
Shareholders' Equity	2,318	2,318	2,369	2,339	2,305	2,666
Total Liabilities & Equity	4,519	4,519	4,685	4,641	4,977	4,698
Total Debt	1,703	1,703	1,798	1,853	2,102	1,369
Net Cash (Debt)	-1,524	-1,524	-1,461	-1,551	-1,594	-1,080
Net Cash Per Share	-1.73	-1.73	-1.45	-1.76	-1.64	-1.12
Filing Date Shares Outstanding	617.06	617.06	966.49	966.49	966.49	966.49
Total Common Shares Outstanding	617.06	617.06	966.49	966.49	966.49	966.49
Working Capital	538.72	538.72	566.51	-875.86	765.54	782.39
Book Value Per Share	3.76	3.76	2.42	2.39	2.35	2.72
Tangible Book Value	2,114	2,114	2,118	2,071	2,019	2,359
Tangible Book Value Per Share	3.43	3.43	2.19	2.14	2.09	2.44
Buildings	-	-	685.07	682.42	557.14	554.27
Machinery	-	-	425.08	419.56	411.47	406.82
Construction In Progress	-	-	267.39	259.15	271.2	257.51

Source: S&P Capital IQ. Standard template. Financial Sources.